Mitigating doping risk by reducing the use of tainted supplements

Dr. Amy Eichner received her PhD in neuroscience from Australian National University in 2001 and continued in neuromedical research at various places including Harvard University and Massachusetts General Hospital. In 2008, she joined the Therapeutic Goods Administration in Australia to lead a laboratory in biocompatibility testing of medical devices. She has worked with the U.S. Anti-Doping Agency in the Drug Reference Department since 2009 on the Drug Reference Hotline, Global Drug Reference Online database, Therapeutic Use Exemptions, and Supplement Connect (formerly Supplement 411), and she is now the Special Advisor on Drugs and Supplements for USADA.